IMG_Apr72021at20024PM.jpg
ImplantsPixium Puts Second Sight in Rear View with Pivotal TrialPixium Puts Second Sight in Rear View with Pivotal Trial
Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic vision system for atrophic dry age-related macular degeneration.
Sign up for the QMED & MD+DI Daily newsletter.